Why Thermo Fisher Scientific Inc. is a Must-Have in Your Portfolio!
Thermo Fisher Scientific Inc. is the largest high-technology company in the world. It offers products and services for science, creating and manufacturing products for scientific research and diagnostics. Its clients include pharmaceutical and biotechnology companies, hospital diagnostic laboratories, universities, research institutes, government agencies, and other institutions worldwide.
Financial Performance and Ratios
In Q3 2024, Thermo Fisher reported revenue of $10.60 billion and GAAP diluted earnings per share (EPS) of $4.25. Financial Ratios: Price-to-Earnings (P/E) Ratio: 32.52, Price-to-Sales (P/S) Ratio: 4.69, Price-to-Book (P/B) Ratio: 4.05, Return on Equity (ROE): 12.94%, Return on Assets (ROA): 4.67%; Debt-to-Equity Ratio: 0.72.
Stock Price Performance
Thermo Fisher Scientific Inc. (NYSE: TMO) has shown a strong performance in the stock market. As of the latest data, the stock price is around $518.84, with a market capitalization of approximately $198.46 billion. Over the past year, the stock has experienced fluctuations but has generally trended upwards.
Investment Insight
The company is an exceptional cash flow generator, a fact well-recognized by market participants. This is reflected in the impressive 10-year Compound Annual Growth Rate (CAGR) of the stock price, which stands at 15.34%. Consequently, under favorable market conditions, we anticipate the stock price to continue its growth at this rate, or potentially even accelerate beyond it.
Thermo Fisher Scientific Inc Stock Forecast**
MIN/MAX | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
MIN | 544.23 | 612.86 | 690.14 | 777.17 | 875.17 |
MAX | 692.71 | 780.06 | 878.42 | 989.19 | 1113.93 |
When to buy?
Currently, the stock price is in a consolidation phase following a slight correction from its all-time high (ATH). This period presents a favorable opportunity for purchasing or augmenting your portfolio. However, further corrections may occur in the near future, potentially allowing you to buy at an even lower price and enhance your returns.
Dividend Policy
Thermo Fisher Scientific Inc. has a modest dividend policy. The current dividend yield is 0.30%, with a payout ratio of 9.78%. This indicates that the company returns a small portion of its earnings to shareholders in the form of dividends, while retaining most of the profits for reinvestment and growth.
Conclusion
Thermo Fisher Scientific Inc. is a leading high-technology company with robust financial performance and a strong track record in the stock market. The company’s ability to generate exceptional cash flow, coupled with its impressive 10-year CAGR, indicates a promising future for investors. As the stock currently consolidates, it presents a favorable buying opportunity, though further corrections may offer even better entry points.
A cup of coffee from you for this excellent analysis.
Or donate:
Make a one-time donation
Choose an amount
Or enter a custom amount
Your contribution is appreciated.
DonateCompany’s Site.
More US Stocks.
*Investment analysis involves scrutinizing over 50 different criteria to assess a company's ability to generate shareholder value. This comprehensive approach includes tracking revenue, profit, equity dynamics, dividend payments, cash flow, debt and financial management, stock price trends, bankruptcy risk, F-Score, and more. These metrics are consolidated into a straightforward Investment Scoreboard, which effectively helps predict future stock price movements.
**Use the price forecast to manage the risk of your investments.